Ka Meghalayan Medical Drugs & Services Ltd kaba don hapoh jong ka Department of Health & Family Welfare jong ka sorkar jylla lyngba u Managing Director jong ka u Ramkumar S, ula pynmih ia ka jingpynshai ha ka jingiadei bad ka jingmih ki jingartatien halor u dawai Albendazole, da kaba pyntip ba une u dawai u long uba shngaiñ ban pyndonkam.
Ka khubor na katei ka tnad ka iathuh ba ia utei u dawai tablet (Albendazole tablets) batch No. MS4A12301 (Manufacturing Date” Jan-2023, Expiry Date: Dec-2025) la dep ban sam sha ki District hapoh ka Jylla katkum ka jingmang ia ki, hadien ba la dep ban pynlong ia ka test ha u bnai Rymphang (February) 2023. Ia ka test la pynlong ha ki ar jaka, kawei ka Manufacturer’s in-house quality Test bad ka National Accreditation Board fo Testing and Calibration Laboratories (NABL) baroh ar ki ai ia ka riport kaba biang bad long shngaiñ ban pyndonkam.
Hynrei ka la don ka jingujor na ka ka Regional Drug Testing Lab (RDTL), Assam ha u bnai October 2023 kaba pynpaw ba utei u dawai um long uba shngaiñ ban dih.
Mar mar na ka liang ka tnad ba dei peit ka Quality Control Division of Meghalaya Medical & Services Ltd kala phah test biang ia une u dawai ha u bnai November 2023 da kaba phah sha ka NABL, Kolkata. Katkum ka ripot kaba la ba la ai da kane ka jaka test ka pynpaw ba une u dawai u long uba shngaiñ ban dih.